|
FNBP1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.979700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.572790E-01 |
| Normal-vs-Stage2 |
2.877200E-01 |
| Normal-vs-Stage3 |
9.699100E-03 |
| Normal-vs-Stage4 |
4.165800E-04 |
| Stage1-vs-Stage2 |
9.699200E-01 |
| Stage1-vs-Stage3 |
5.220400E-02 |
| Stage1-vs-Stage4 |
2.096200E-03 |
| Stage2-vs-Stage3 |
2.326200E-01 |
| Stage2-vs-Stage4 |
5.101800E-02 |
| Stage3-vs-Stage4 |
2.769400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.556000E-02 |
| Normal-vs-AfricanAmerican |
9.935200E-01 |
| Normal-vs-Asian |
4.885800E-02 |
| Caucasian-vs-AfricanAmerican |
1.411800E-01 |
| Caucasian-vs-Asian |
7.904800E-01 |
| AfricanAmerican-vs-Asian |
1.399240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.717900E-02 |
| Normal-vs-Female |
4.951700E-02 |
| Male-vs-Female |
7.691600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.499600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.140300E-02 |
| Normal-vs-Age(61-80Yrs) |
1.441340E-03 |
| Normal-vs-Age(81-100Yrs) |
4.758400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.903800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.916900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.844580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.290000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.068200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.469200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.579750E-02 |
| Classical-VS-Follicular |
3.390600E-01 |
| Classical-VS-Other |
6.916800E-01 |
| Classical-VS-Normal |
1.457780E-01 |
| Tall-VS-Follicular |
2.072200E-01 |
| Tall-VS-Other |
1.302170E-01 |
| Tall-VS-Normal |
4.944100E-03 |
| Follicular-VS-Other |
5.282800E-01 |
| Follicular-VS-Normal |
7.213800E-02 |
| Other-VS-Normal |
8.437400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.437700E-02 |
| Normal-vs-N1 |
5.880500E-03 |
| N0-vs-N1 |
3.641200E-01 |
|
|
